Sangamo Therapeutics, Inc. (0R1D.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
At close: 06:57PM BST
| Previous close | 0.5260 |
| Open | 0.5346 |
| Bid | 0.0000 x N/A |
| Ask | 0.0000 x N/A |
| Day's range | 0.5220 - 0.5500 |
| 52-week range | 0.2900 - 2.1105 |
| Volume | |
| Avg. volume | 47,193 |
| Market cap | 666,638 |
| Beta (5Y monthly) | 1.35 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Cardiff Oncology (CRDF) Reports Q1 Loss, Tops Revenue Estimates
Cardiff Oncology (CRDF) delivered earnings and revenue surprises of 12% and 86.36%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
- Simply Wall St.
What You Need To Know About The Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Analyst Downgrade Today
One thing we could say about the analysts on Sangamo Therapeutics, Inc. ( NASDAQ:SGMO ) - they aren't optimistic...
- Simply Wall St.
Sangamo Therapeutics Full Year 2023 Earnings: Misses Expectations
Sangamo Therapeutics ( NASDAQ:SGMO ) Full Year 2023 Results Key Financial Results Revenue: US$176.2m (up 58% from FY...
© 2024 Yahoo. All rights reserved.